Sony T
One of the largest premier Institute that is Indian Institute of Technology (IIT) Mandi which is located in the state of Himachal Pradesh, has join hands with RxDataScience Inc, which is a American-based healthcare-focussed big data analytics software firm, to bring a documentation portal for the Machine Learning and Artificial Intelligence in the pharmaceutical sector.
A team of some of the people from the IIT Mandi will also work closely with RxDataScience Inc, to apply deep-learning methods and cognitive algorithms for discovering patterns which is mostly among the patient journeys and social ties among physicians. This is going to be a long term association which is going to be focused more on the machine learning performance on the healthcare sector with respect to patients and physicians and also to develop some of the web based visualizations.
“As of now the Data Scientist in India is still at a growing stage yet but in the US, most healthcare and pharmaceutical companies have moved onto the consulting stage wherein live cases are debated online by the doctors and medical practitioners’ community,” said Prof. Varun Dutt, assistant professor, school of computing and electrical engineering, IIT Mandi, while explaining the importance of collaboration with RxDataScience.
As of now we all know that India is at the helm of the healthcare boom which is providing the government of India that hiked in the health spending by around 11% with a gross budgetary allocation of Rs 1200 crore.
“State-of-the-art infrastructure on ground can help only when off ground data science evolves and put the registers and medical charts online up for discussion with other doctors. IIT Mandi is pleased to work with such a nodal agency in the healthcare sector the world over and this puts India on the world map of healthcare mapping online,” said Prof. Dutt further.
Just to recall, in the month of April, a Swiss multinational healthcare firm Roche announced that is also going to start a startup in India with the help of company which bring evidence based on the ML in India with the help of its latest proprietary technology.
